Clinical Trial Update: Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating N-acetylcysteine for neuroprotection in progressive multiple sclerosis; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multiple Sclerosis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Emmanuelle Waubant, MD PhD | Conditions: Multiple Sclerosis, Multiple Sclerosis, Primary Progressive | Phase 2 | Status: ACTIVE_NOT_RECRUITING